Priaxon AG Appoints Dr Constance Hoefer as Chief Development Officer
Priaxon AG, a privately held pharmaceutical company developing novel small molecule agents for the modulation of protein…
Priaxon AG, a privately held pharmaceutical company developing novel small molecule agents for the modulation of protein…
Proteros biostructures GmbH ("Proteros") today announced that the company entered into a Lead Discovery Collaboration wi…
Priaxon, an emerging pharmaceutical company based in Germany, today announced a collaboration with GlaxoSmithKline (GSK)…
Ontochem GmbH ("Ontochem") and Priaxon AG, Munich, Germany ("Priaxon) today announced the entry into a collaboration and…
Kinaxo Biotechnologies GmbH announced today that it was awarded a grant by the Bavarian Research Foundation (Bayerische…